We talk with Dr. Andrew Horwitz Vice President, R&D at Sestina Bio LLC about producing cannabinoids outside the cannabis plant. Previously, Andrew managed the Cannabinoid R&D program at Demetrix, where he helped develop the process for using genetically modified yeast cells to produce cannabinoids. We discuss:



The advantages of using yeast cells to produce cannabinoids instead of cannabis and hemp plants How adjusting the precursor molecules that are fed to the yeast cells can produce rare and novel cannabinoidsHow cannabis medicine researchers can use this technology to better understand the entourage effectWhy understanding the way the cannabis plant produces cannabinoids was essential to developing this technology How this technology is received by the cannabis community 



Thanks to our Sponsor: Demetrix



Demetrix is a biotechnology company that believes in the power of science to make the world a better place. The company produces safe, legal, and effective health and wellness products backed by science, including rare, high-purity cannabinoids for pharmaceutical and consumer applications.



To learn more, please visit www.demetrixbio.com, and be sure to check out their blog, www.demetrixbio.com/insights. 



Additional Resources



"Developing Fermentation Technology to Produce Specific Cannabinoids for Research and Consumer Use" Andrew Horwitz, PhD, CannMed 2019Sestina Bio, LLC website Demetrix blog Luo, Xiaozhou et al. “Complete biosynthesis of cannabinoids and their unnatural analogues in yeast.” Inscripta Onyx